Maze Therapeutics, Inc. (MAZE)

45.84 -1.39 (-2.94%) USD  |  NASDAQ  |  Feb 26, 16:00
46.06 +0.22 (+0.47%) After-Hours: 20:00
More

Maze Therapeutics Stock Based Compensation (Annual)

Stock Based Compensation (Annual) Chart

View Stock Based Compensation (Annual) for MAZE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (Annual) Range, Past 5 Years

View Stock Based Compensation (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (Annual) Benchmarks

View Stock Based Compensation (Annual) Benchmarks
Start Trial
CDT Equity, Inc. Upgrade
LENZ Therapeutics, Inc. Upgrade
Liminatus Pharma, Inc. --
Oruka Therapeutics, Inc. Upgrade
MapLight Therapeutics, Inc. Upgrade